Showing 861-870 of 9325 results for "".
Advances in Tattoo Removal and More
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/advances-in-tattoo-removal-and-more/19756/Eric Bernstein, MD shares insights on the benefits of picosecond domain lasers for everything from rejuvenation to tattoo removal. He discusses his recent experience with the 730nm handpiece and its efficacy on multiple ink colors and all skin types. In addition, he talks about other new technologieDermWireTV: Latest on Galderma, Eczema Awareness, Hacking Derm, and More
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-latest-on-galderma-eczema-awareness-hacking-derm-and-more/19675/In this week’s edition: Galderma’s Aklief (trifarotene) topical cream is now approved for acne. Sandra Johnson, MD weighs in. Supported by Sanofi and Regeneron in partnership with the National Eczema Association, the Understand AD Squad includes dermatologist Mercedes Gonzalez, MD, who discusses herABD Eyes Mohs Certification, Sun's Ilumya Approved, FUE Update
https://practicaldermatology.com/topics/psoriasis/dermwiretv-abd-eyes-mohs-certification-sun-s-ilumya-approved-fue-update/18319/The American Board of Dermatology has notified the American Board of Medical Specialties it wants to offer a subspecialty certificate in Micrographic Dermatologic Surgery. Dermatologists react. Ilumya or tildrakizumab from Sun Pharma is approved for moderate to severe psoriasis. Medicine the MusicalTo Be Shorr: Use Call Tracking Numbers to Measure Your Marketing ROI
https://practicaldermatology.com/topics/practice-management/to-be-shorr-use-call-tracking-numbers-to-measure-your-marketing-roi/18604/Tracking ROI on your marketing initiatives is an important but sometimes challenging undertaking. In this edition of "To Be Shorr," Mara Shorr, BS, CAC II-V shares tips for easily tracking your investments, including the use of call tracking numbers.ASDS: Dr. Munavalli on Combining Lasers and Topicals for Skin Cancer
https://practicaldermatology.com/conferences/asds-2024-annual-meeting/asds-dr-munavalli-combining-lasers-and-topicals-skin-cancer/29151/Girish Munavalli, MD, MHS, FAAD, discusses his lecture on lasers in combination with topical medications in the treatment of skin cancer at the 2024 American Society for Dermatologic Surgery Annual Meeting.Therapeutic Advances and Fighting for Authorizations
https://reachmd.com/programs/practical-dermatology/therapeutic-advances-and-fighting-for-authorizations/35890/Joel L. Cohen, MD, FAAD, and Leon Kircik, MD, FAAD, discuss the latest developments in psoriasis and atopic dermatitis, as well as the challenges involved with fighting for prior authorizations for the best therapies, at Music City SCALE 2025.ASDS: Dr. Downie on Diversity in Dermatology
https://practicaldermatology.com/conferences/asds-2024-annual-meeting/asds-dr-downie-diversity-dermatology/29154/Jeanine B. Downie, MD, FAAD, discusses survey data on different ethnic groups’ cosmetic preferences and the importance of diversity in dermatology at the 2024 American Society for Dermatologic Surgery Annual Meeting.DermWireTV: New Data Presented for Atopic Dermatitis and Prurigo Nodularis Candidates at AAD
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-new-data-presented-for-atopic-dermatitis-and-prurigo-nodularis-candidates-at-aad/24127/In this episode of DermWireTV, a phase 3 study finds roflumilast cream is associated with significantly improved atopic dermatitis in children; first-of-its-kind research suggests that eczema treatment lebrikizumab shows efficacy and safety in patients with skin of color; and new data reveals oral JDermWire TV: Positive Data on UCB's Bimekizumab in HS patients; CSF takes Nashville by Storm; Rocatinlimab Performs Well in AD
https://practicaldermatology.com/topics/psoriasis/dermwire-tv-positive-data-on-ucbs-bimekizumab-hs-patients-csf-takes-nashville-by-storm-rocatinlimab-performs-well-in-ad/20159/Bimekizumab performs well in Hidradenitis Suppurativa patients, Cosmetic Surgery Forum takes Nashville by storm, and Rocatinlimab—a novel monoclonal antibody therapy—shows promise in atopic dermatitis are the stories topping the news in this episode of DermWireTV.DermWireTV: Medicare Cuts; Revision, Alastin, Obagi Acquisitions; CSF Hits Nashville
https://practicaldermatology.com/topics/practice-management/dermwiretv-medicare-cuts-revision-alastin-obagi-acquisitions-csf-hits-nashville/20033/Congress is working to avert a potential pay cut for physicians who treat Medicare patients, and a bipartisan solution has been introduced. Cuts loom as the AMA has released data showing that Medicare claims data exclusive to physician services fell an estimated $13.9 billion or 14 percent below exp